27.1 C
New Delhi
Monday, April 29, 2024
Home Tags Turalio Risk Evaluation and Mitigation Strategy

Tag: Turalio Risk Evaluation and Mitigation Strategy

USFDA approves Daiichi Sankyo’s Turalio, a drug for rare joint tumour

Turalio has been approved for tenosynovial giant cell tumour that can cause debilitating symptoms for patients such as pain, stiffness   The U.S. Food and Drug Administration...